- Home
- SBH vs WVE Comparison
SBH vs WVE Comparison
Compare SBH & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBH
- WVE
- Stock Information
- Founded
- SBH 1964
- WVE 2012
- Country
- SBH United States
- WVE Singapore
- Employees
- SBH N/A
- WVE N/A
- Industry
- SBH Other Specialty Stores
- WVE Biotechnology: Pharmaceutical Preparations
- Sector
- SBH Consumer Discretionary
- WVE Health Care
- Exchange
- SBH Nasdaq
- WVE Nasdaq
- Market Cap
- SBH 1.0B
- WVE 915.6M
- IPO Year
- SBH 2006
- WVE 2015
- Fundamental
- Price
- SBH $14.40
- WVE $9.62
- Analyst Decision
- SBH Buy
- WVE Strong Buy
- Analyst Count
- SBH 5
- WVE 16
- Target Price
- SBH $12.88
- WVE $20.00
- AVG Volume (30 Days)
- SBH 2.3M
- WVE 1.6M
- Earning Date
- SBH 08-05-2025
- WVE 07-30-2025
- Dividend Yield
- SBH N/A
- WVE N/A
- EPS Growth
- SBH 35.04
- WVE N/A
- EPS
- SBH 1.85
- WVE N/A
- Revenue
- SBH $3,689,376,000.00
- WVE $93,946,000.00
- Revenue This Year
- SBH $0.13
- WVE N/A
- Revenue Next Year
- SBH $1.29
- WVE $10.02
- P/E Ratio
- SBH $7.69
- WVE N/A
- Revenue Growth
- SBH N/A
- WVE N/A
- 52 Week Low
- SBH $7.54
- WVE $5.04
- 52 Week High
- SBH $14.79
- WVE $16.74
- Technical
- Relative Strength Index (RSI)
- SBH 71.67
- WVE 59.16
- Support Level
- SBH $13.32
- WVE $9.26
- Resistance Level
- SBH $14.23
- WVE $10.45
- Average True Range (ATR)
- SBH 0.53
- WVE 0.53
- MACD
- SBH 0.01
- WVE -0.03
- Stochastic Oscillator
- SBH 97.44
- WVE 55.96
About SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.